| Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
| PPP3CB |
protein phosphatase 3, catalytic subunit, beta isozyme |
10q22.2 |
2(1/1/0)
|
TAS[21531385]
|
| CNR1 |
cannabinoid receptor 1 (brain) |
6q14-q15 |
5(0/5/0)
|
IEA
|
| SHANK2 |
SH3 and multiple ankyrin repeat domains 2 |
11q13.2 |
2(1/1/0)
|
IEA
|
| GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
1(1/0/0)
|
IEA
|
| SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
17q11.2 |
44(18/26/0)
|
IEA
|
| GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
12p13.1 |
8(4/4/0)
|
IEA
|
| CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
15q13.3 |
4(2/2/0)
|
NAS[10681545]
|
| S100B |
S100 calcium binding protein B |
21q22.3 |
2(1/1/0)
|
IEA
|
| ATP1A3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
19q13.2 |
3(2/1/0)
|
IEA
|
| PDE4D |
phosphodiesterase 4D, cAMP-specific |
5q12 |
1(0/1/0)
|
IEA
|
| HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
22(7/15/0)
|
IEA
|
| NGF |
nerve growth factor (beta polypeptide) |
1p13.1 |
2(1/1/0)
|
IEA
|
| TH |
tyrosine hydroxylase |
11p15.5 |
16(4/12/0)
|
ISS
|
| CRHR1 |
corticotropin releasing hormone receptor 1 |
17q21.31 |
4(2/2/0)
|
IEA
|
| CREB1 |
cAMP responsive element binding protein 1 |
2q34 |
2(1/1/0)
|
IEA
|
| IL1RN |
interleukin 1 receptor antagonist |
2q14.2 |
2(2/0/0)
|
IEA
|
| CHRNB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
1q21.3 |
1(1/0/0)
|
IMP[15964197]
|
| PLA2G6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
22q13.1 |
2(1/1/0)
|
IEA
|
| KLK8 |
kallikrein-related peptidase 8 |
19q13 |
1(1/0/0)
|
ISS
|
| DBH |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
9q34 |
3(1/2/0)
|
IEA
|
| DRD1 |
dopamine receptor D1 |
5q34-q35 |
11(6/5/0)
|
IEA
|
| OXTR |
oxytocin receptor |
3p25 |
1(0/1/0)
|
IEA
|
Basic Info
